ASSOCIATION OF LIPOPROTEIN(A) WITH PUBERTY IN IDDM

被引:40
作者
COUPER, JJ
BATES, DJ
COCCIOLONE, R
MAGAREY, AM
BOULTON, TJC
PENFOLD, JL
RYALL, RG
机构
[1] UNIV ADELAIDE,ADELAIDE CHILDRENS HOSP,DEPT ENDOCRINOL & DIABET,ADELAIDE,SA 5006,AUSTRALIA
[2] UNIV ADELAIDE,ADELAIDE CHILDRENS HOSP,DEPT CHEM PATHOL,ADELAIDE,SA 5006,AUSTRALIA
[3] UNIV ADELAIDE,ADELAIDE CHILDRENS HOSP,DEPT NUTR & DIETET,ADELAIDE,SA 5006,AUSTRALIA
[4] UNIV NEWCASTLE,DEPT PEDIAT,NEWCASTLE,NSW 2308,AUSTRALIA
关键词
D O I
10.2337/diacare.16.6.869
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE- To determine serum lipoprotein(a) in a large sample of IDDM and control children and to examine a possible association with puberty. RESEARCH DESIGN AND METHODS- Serum lipoprotein(a), apoB-100, and apoA-I were measured under identical conditions in 170 Caucasian children with IDDM aged 12.3 +/- 3.59 yr and 233 Caucasian control children aged 13.6 +/- 1.12 yr. Patients with persistent microalbuminuria were excluded. Lipoprotein(a), apoB-100, and apoA-I were measured by nephelometry using a specific monoclonal antibody. Pubertal assessment was performed using Tanner staging and testicular volume measurement. RESULTS - Lipoprotein(a) was higher in the IDDM than control group (geometric mean 237 mg/L, 25-75th percentile 134-465 vs. 172 [99-316] mg/L, P = 0.0008). When analyzed according to pubertal stage, only pubertal and postpubertal patients had higher levels than control subjects (265 [148-560] vs. 174 [101-320] mg/L, P = 0. 000 1), with prepubertal patients showing no difference. Pubertal and postpubertal patients showed both higher lipoprotein(a) (P = 0.01) levels and higher albumin excretion rates (P = 0.02) than prepubertal patients, correcting for the other variable. Lipoprotein(a) was not related to HbA1c, albumin excretion rate, duration, age, sex, mean arterial pressure, or a family history of premature coronary artery disease in the IDDM group. Lipoprotein(a) was not higher in patients with overnight albumin excretion rate above the 95th percentile but below the microalbuminuric range. ApoB-100 did not differ between IDDM and control children. ApoA-I was significantly lower in the IDDM group (1.04 [0.94-1.17] vs. 1.21 [1.10-1.31] g/L; P < 0.0001). CONCLUSIONS- Pubertal and postpubertal IDDM patients have higher serum lipoprotein(a) than Caucasian control subjects. Our findings suggest a rise in lipoprotein(a) may occur during puberty in IDDM. Longitudinal studies are required to clarify the relationship between lipoprotein(a), albumin excretion rate, and puberty.
引用
收藏
页码:869 / 873
页数:5
相关论文
共 35 条
  • [21] MOLECULAR-BASIS OF APOLIPOPROTEIN-(A) ISOFORM SIZE HETEROGENEITY AS REVEALED BY PULSED-FIELD GEL-ELECTROPHORESIS
    LACKNER, C
    BOERWINKLE, E
    LEFFERT, CC
    RAHMIG, T
    HOBBS, HH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) : 2153 - 2161
  • [22] AUTOMATED MEASUREMENT OF LIPOPROTEIN(A) BY IMMUNOTURBIDIMETRIC ANALYSIS
    LEVINE, DM
    SLOAN, BJ
    DONNER, JE
    LORENZ, JD
    HEINZERLING, RH
    [J]. INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1992, 22 (03) : 173 - 178
  • [23] LIPOPROTEIN(A) LEVELS IN BLACK-AND-WHITE CHILDREN AND ADOLESCENTS WITH IDDM
    LEVITSKY, LL
    SCANU, AM
    GOULD, SH
    [J]. DIABETES CARE, 1991, 14 (04) : 283 - 287
  • [24] CDNA SEQUENCE OF HUMAN APOLIPOPROTEIN(A) IS HOMOLOGOUS TO PLASMINOGEN
    MCLEAN, JW
    TOMLINSON, JE
    KUANG, WJ
    EATON, DL
    CHEN, EY
    FLESS, GM
    SCANU, AM
    LAWN, RM
    [J]. NATURE, 1987, 330 (6144) : 132 - 137
  • [25] LOW PLASMA GROWTH-HORMONE BINDING-PROTEIN IN IDDM
    MERCADO, M
    MOLITCH, ME
    BAUMANN, G
    [J]. DIABETES, 1992, 41 (05) : 605 - 609
  • [26] MUHTASEB N, 1992, PEDIATRICS, V89, P936
  • [27] PHILCOX JC, 1992, CLIN CHEM, V38, P1488
  • [28] LIPOPROTEIN (A) LEVELS IN DIABETES-MELLITUS - RELATIONSHIP TO METABOLIC CONTROL
    RAMIREZ, LC
    ARAUZPACHECO, C
    LACKNER, C
    ALBRIGHT, G
    ADAMS, BV
    RASKIN, P
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 117 (01) : 42 - 47
  • [29] LP(A) LIPOPROTEIN AS A RISK FACTOR FOR MYOCARDIAL-INFARCTION
    RHOADS, GG
    DAHLEN, G
    BERG, K
    MORTON, NE
    DANNENBERG, AL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (18): : 2540 - 2544
  • [30] LP(A) SERUM CONCENTRATIONS AND METABOLIC CONTROL
    RITTER, MM
    RICHTER, WO
    LYKO, K
    SCHWANDT, P
    [J]. DIABETES CARE, 1992, 15 (10) : 1441 - 1442